Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

The Dream of Plasma Proteomics – Translating Proteomics Episode 11

Key Takeaway: In the latest episode of Translating Proteomics, hosts Parag Mallick and Andreas Huhmer explore the potential of plasma proteomics in biomarker discovery. They discuss the advantages of using plasma as a source for protein biomarkers, the challenges faced in measuring protein levels, and the future direction of plasma biomarker research. The episode emphasizes the need for advancements in methodologies to fully realize the promise of plasma proteomics.
Price reaction · baseline $2.81 (2024-10-28 close) · hit after-hours · 4 other NAUT headline(s) in the window, move may be shared
day 0 close
-1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Plasma proteomics offers a promising source for protein biomarkers.
  • The discussion highlights advancements in plasma biomarker discovery.
  • Non-invasive collection methods for plasma are beneficial for patients.

CONCERNS & RISKS

  • Measuring plasma protein levels is challenging due to wide concentration ranges.
  • Current methodologies have limitations that need addressing.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

Applications of Proteomics
Nautilus Biotechnology
October 28, 2024
On this episode of Translating Proteomics, hosts Parag Mallick and Andreas Huhmer discuss the challenges and opportunities of plasma proteomics. Their conversation focuses on:
• Why blood plasma may be a good source of protein biomarkers
• Current methodologies and pitfalls in plasma proteomics
• The path forward for plasma proteomics
Find this episode on Apple Podcasts , Spotify , or YouTube .
Browse all episodes of Translating Proteomics.

Translating Proteomics Episode 11 - Plasma Proteomics - The Dream and the Nightmare

Stream the episode on YouTube

What is Plasma Proteomics?

For those who are new to this topic, plasma is the liquid portion of the blood distinct from fractions containing red and white blood cells. Given the relatively non-invasive ways physicians can collect patient plasma, and the blood’s intimate association with tissues throughout the body, plasma is potentially an excellent source of protein biomarkers . Yet, it is quite difficult to measure the levels of all plasma proteins because their concentrations span over 12 orders of magnitude . This episode features an in-depth discussion of the ways plasma proteomics efforts have and have not lived up to the promise of biomarker discovery and what we can do to advance plasma biomarker discovery efforts in the future.

Chapters

00:00 – 01:01 – Intro
01:02 – 4:55 – What is the promise of plasma proteomics?
04:55 – 07:23 – Is the plasma proteome really the best source of biomarkers?
07:23 – 10:16 – How do proteins get in the blood and what are the implications for biomarker discovery?
10:16 – 13:59 – Is it clear that proteins are the best candidates for blood biomarkers?
13:59 – 19:57 – Advances in and the future of comprehensive plasma proteomics
19:57 – 22:31 – Pros and cons of fractionating the plasma proteome to discover biomarkers
22:31 – 28:14 – Progress in identifying multiomic plasma biomarkers and the path forward
28:14 – End – Outro

Resources

• Nano-omics: nanotechnology-based multidimensional harvesting of the blood-circulating cancerome (Gardner et al. 2022) Review from focused on the development multiomics liquid biopsies
• Multicompartment modeling of protein shedding kinetics during vascularized tumor growth (Machiraju et al. 2020) Work from Parag’s Lab looking at tumor protein shedding
• Simulation of the Protein-Shedding Kinetics of a Fully Vascularized Tumor (Frieboes et al. 2015) Tumor protein shedding work from Parag’s Lab
• Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations (Hori and Gambhir et al. 2011) Study modeling how much protein could be shed and detected from different size tumors
• The human plasma proteome: history, character, and diagnostic prospects (Anderson and Anderson 2002) Review discussing the clinical importance of the plasma proteome and the wide range of protein abundance in the plasma proteome
• Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care (Palmqvist et al. 2024) An example of the potential power of blood plasma as a source of biomarkers
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Proteomics applications in medicine, basic biology, and beyond
Proteomics is being applied in many biological fields to unlock new discoveries and drive scientific advances.
Read more
White paper series: The proteomics revolution
This post contains white papers describing how developments in proteomics - led by the Nautilus platform - will improve healthcare.
Read more
Targeting healthcare disparities through the proteomics revolution (Part 1)
Learn how biases have led to inequities in healthcare and how researchers can rectify those inequities with better data.
Read more
Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Frequently Asked Questions

What is plasma proteomics?

Plasma proteomics studies the proteins in blood plasma, aiming to identify biomarkers for diseases.

Why is plasma a good source for biomarkers?

Plasma is easily collected and reflects the body's tissue interactions, making it ideal for biomarker discovery.

What challenges exist in plasma proteomics?

Challenges include the difficulty in measuring protein levels due to their vast concentration differences.

What advancements are discussed in the episode?

The episode highlights progress in identifying multiomic plasma biomarkers and the future of proteomics.

Last updated: Oct 28, 2024